RNPC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.556800E-01
Normal-vs-Stage2
4.116400E-01
Normal-vs-Stage3
2.677800E-01
Normal-vs-Stage4
3.692200E-01
Stage1-vs-Stage2
1.776400E-01
Stage1-vs-Stage3
1.071520E-02
Stage1-vs-Stage4
6.157400E-01
Stage2-vs-Stage3
5.73369999999906E-05
Stage2-vs-Stage4
6.190000E-01
Stage3-vs-Stage4
1.136630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.074200E-01
Normal-vs-AfricanAmerican
2.257200E-01
Normal-vs-Asian
3.684000E-01
Caucasian-vs-AfricanAmerican
9.032600E-01
Caucasian-vs-Asian
4.731600E-01
AfricanAmerican-vs-Asian
7.551600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.015800E-01
Normal-vs-Female
4.083800E-01
Male-vs-Female
8.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.091400E-01
Normal-vs-Age(41-60Yrs)
4.243600E-01
Normal-vs-Age(61-80Yrs)
3.957600E-01
Normal-vs-Age(81-100Yrs)
3.908600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.881000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.097400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.835400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.028200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.539600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.762600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.891000E-01
Normal-vs-Daily Drinker
3.908600E-01
Normal-vs-Weekly Drinker
3.657400E-01
Normal-vs-Occasional Drinker
3.808800E-01
Normal-vs-Social Drinker
5.406600E-01
Non Drinker-vs-Daily Drinker
9.888200E-01
Non Drinker-vs-Weekly Drinker
6.742000E-01
Non Drinker-vs-Occasional Drinker
8.736400E-01
Non Drinker-vs-Social Drinker
6.829800E-02
Daily Drinker-vs-Weekly Drinker
6.908600E-01
Daily Drinker-vs-Occasional Drinker
8.739600E-01
Daily Drinker-vs-Social Drinker
1.006020E-01
Weekly Drinker-vs-Occasional Drinker
7.821600E-01
Weekly Drinker-vs-Social Drinker
6.412100E-02
Occasional Drinker-vs-Social Drinker
6.942200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.597760E-01
Normal-vs-Grade 2
2.728200E-02
Normal-vs-Grade 3
6.107600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.896000E-01
Grade 1-vs-Grade 3
3.919400E-01
Grade 1-vs-Grade 4
1.597760E-01
Grade 2-vs-Grade 3
9.147400E-01
Grade 2-vs-Grade 4
2.728200E-02
Grade 3-vs-Grade 4
6.107600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.638800E-01
Normal-vs-NonDiabetic
4.012400E-01
Diabetic-vs-NonDiabetic
2.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.521800E-01
Normal-vs-NoPancreatitis
3.842600E-01
Pancreatitis-vs-NoPancreatitis
3.067200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.049400E-01
Normal-vs-N1
4.041200E-01
N0-vs-N1
9.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.145000E-01
Normal-vs-TP53-NonMutant
4.637600E-01
TP53-Mutant-vs-TP53-NonMutant
3.077600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
